comparemela.com

Latest Breaking News On - Pharmaceuticals - Page 1 : comparemela.com

AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts

/PRNewswire/ The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. This report.

Laura woodHealthcare iot innovation centerAcquisition networkE st office hours callAstrazeneca plcOffice hours callZeneca plcMachine learning ledger orchestrationDrug discoveryTopics coveredFree callHours callResearch and marketsHealth care amp hospitalsPublishing amp information servicesMedical pharmaceuticals

CEO of Kelun-Biotech Dr Micheal Ge delivered a presentation on The 42nd JPM Annual Healthcare Conference

/PRNewswire/ The 42nd J.P. Morgan Annual Healthcare Conference（"JPMHC"）2024 is taking place on January 8-11 at San Fracisco, USA, members of Sichuan.

United statesSichuan kelunBiotech biopharmaceutical co ltdKelun groupAnnual healthcare conferenceSan fraciscoPacific standard timeKelun biotechHealth care amp hospitalsMedical pharmaceuticals

WBA (Walgreens Boots Alliance) Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, Partnership, Investment & Acquisition Network Map, and Other Innovation Programs

/PRNewswire/ The "WBA - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. Walgreens Boots Alliance Inc.

Laura woodLiz earleE st office hours callWalgreens boots alliance incAlliance healthcareInvestment acquisition networkDuane readeOffice hours callBoots alliance incWalgreens boots allianceTopics coveredAcquisition networkSenior managerFree callHours callResearch and markets

Samsung Biologics presents 2024 business plans at J P Morgan Healthcare Conference

/PRNewswire/ Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today presented its 2024 business.

South koreaSan franciscoUnited statesNew jerseyInch on gwangyoksiPrnewswire samsung biologicsSamsung biologicsSamsung biologics americaSamsung biologics co ltdHealthcare conferenceJohn rimBio campusHealth care amp hospitalsMedical pharmaceuticalsGeneral manufacturingCorporate expansion

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）

/PRNewswire/ On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor.

Hong kongEuropean unionAbbisko therapeutics co ltdEuropean medicines agencyHong kong stock exchangeAbbisko cayman limited stock codeBeijing timeAbbisko therapeuticsPriority medicinesBreak through designationFast track designationAbbisko cayman limitedStock codeHealth care amp hospitalsMedical pharmaceuticals

vimarsana © 2020. All Rights Reserved.